News Releases

Press Releases

Search Press Releases
  
Subscribe for Email Alerts
2/8/2017
8:00 AM ET
Press Release

Diffusion Pharmaceuticals’ TSC Phase 1/2 Glioblastoma Multiforme Clinical Trial Results Published in February 2017 Edition of Journal of Neurosurgery

2/8/2017

CHARLOTTESVILLE, Va., Feb. 08, 2017 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN), a clinical stage biotechnology company focused on the development of novel small molecule therap...

 Continue Reading
12/12/2016
8:30 AM ET
Press Release

Diffusion Pharmaceuticals Files Definitive Proxy Statement for Upcoming Special Meeting of Stockholders

12/12/2016

CHARLOTTESVILLE, Va., Dec. 12, 2016 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN), a clinical stage biotechnology company focused on the development of novel small molecule therap...

 Continue Reading
11/14/2016
8:00 AM ET
Earnings Release

Diffusion Pharmaceuticals Provides Corporate Highlights and Reports Financial Third Quarter 2016 Results

11/14/2016

CHARLOTTESVILLE, Va., Nov. 14, 2016 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN), a clinical stage biotechnology company focused on the development of novel small molecule therap...

 Continue Reading
11/8/2016
8:00 AM ET
Press Release

Diffusion Pharmaceuticals Announces Uplisting to NASDAQ Capital Market

11/8/2016

CHARLOTTESVILLE, Va., Nov. 08, 2016 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (OTCQX:DFFN), a clinical stage biotechnology company focused on the development of novel small molecule therape...

 Continue Reading
9/29/2016
10:05 AM ET
Press Release

Diffusion Pharmaceuticals Establishes Scientific Advisory Board

9/29/2016

CHARLOTTESVILLE, Va., Sept. 29, 2016 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (OTCQX:DFFN), a clinical stage biotechnology company focused on the development of novel small molecule therap...

 Continue Reading
9/19/2016
8:30 AM ET
Press Release

Diffusion Pharmaceuticals Successfully Completes Animal Toxicity Studies in Preparation for Phase 3 Pivotal Trial of TSC in New Diagnosed Glioblastoma Patients

9/19/2016

CHARLOTTESVILLE, Va., Sept. 19, 2016 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (OTCQX:DFFN), a clinical stage biotechnology company focused on the development of novel small molecule therap...

 Continue Reading
9/9/2016
8:30 AM ET
Press Release

Diffusion Pharmaceuticals to Present at 18th Annual Rodman & Renshaw Global Investment Conference

9/9/2016

CHARLOTTESVILLE, Va., Sept. 09, 2016 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (OTCQX:DFFND), a clinical stage biotechnology company focused on the development of novel small molecule thera...

 Continue Reading
Displaying 1 to 7 (of 70 releases)